-
Most Recent
Search Results
240 results for abv
How to Trade This Market Chaos and Come Out Ahead
Fluctuating markets… an ongoing trade war… geopolitical tension… sharp swings in high-valuation tech stocks… these factors have all added to investors’ unease this year. While…
What This 2,000-Year-Old Computer Can Teach Us About Trading Today
Thanks to the biggest breakthrough so far in TradeSmith’s 20-year history, everyday investors like you can now also tap into the power of AI-assisted trading. It…
AbbVie Earnings: 5 Things for ABBV Stock Investors to Note
AbbVie (ABBV) earnings for the biopharmaceutical company’s third quarter of 2019 have ABBV stock up Friday on an EPS and revenue beat.
Earnings Momentum Analytics Power AbbVie (ABBV) to Strong Buy
The current recommendation of Strong Buy for AbbVie Inc (NYSE:ABBV) has been derived by using Louis Navellier’s Portfolio Grader stock evaluator, which incorporates his investing…
Why AbbVie Inc Was a Named Top Dividend Stock (ABBV)
AbbVie Inc has been named to the Dividend Channel’s SAFE dividend list based upon these key metrics
AbbVie (ABBV) a Strong Buy on Best-in-Class Quant Score
AbbVie Inc (NYSE:ABBV) is a constituent of the 350 company Biotechnology GICS industry group, which is a segment of the 782 company GICS Health Care…
AbbVie (ABBV) a Strong Buy on Top-End Earnings Momentum
Portfolio Grader currently ranks AbbVie Inc (NYSE:ABBV) a Strong Buy. The methods for fundamental and quantitative metrics used in this analytical tool, developed by Louis…
AbbVie Earnings: ABBV Stock Falters on Q4 Miss
AbbVie earnings for the fourth quarter of 2018 saw ABBV stock falling today after reporting an earnings per share and revenue miss.
AbbVie Earnings: ABBV Stock Pops on Q2 Beat
AbbVie earnings for the second quarter of 2019 have ABBV stock up on Friday thanks to it beating EPS and revenue estimates.
10 Best “Strong Buy” Stocks — ABG ABT ACHC and more
This week, these ten stocks, all currently earning A’s (“strong buy”) on Portfolio Grader, have the best year-to-date performance. Since the beginning of the year,…
AbbVie Earnings: ABBV Stock Jumps More Than 6% on Q4 Beats
AbbVie (ABBV) earnings for the biopharmaceutical company’s fourth quarter of 2019 have ABBV stock heading higher on Friday.
Trade of the Day: ABBV Stock on the Verge of a Major Breakout
AbbVie Inc is challenging the recent double-top above $65.
How to Trade Stock Market Chaos and Come Out Ahead
Veteran trader Jeff Clark believes we’re in a period of long-term stock market volatility – and that it’s a chance to make outsized gains.
ABBV Stock: The FDA Blow That Just Sent AbbVie Tumbling on Wednesday
Here’s the big FDA-related news today that’s sparking a sharp selloff of pharmaceutical giant AbbVie and ABBV stock.
5 Top Stock Trades for Wednesday: ATVI, SHOP, CHGG, ABT, ABBV
Activision Blizzard, Shopify, Chegg, Abbott Labs and AbbVie were our top stock trades for Wednesday. That said, here’s a look at the charts.
Best Stocks 2022: What’s Not to Like About AbbVie (ABBV) Stock?
ABBV stock has rightly earned its place among the Best Stocks for 2022. This Dividend King is outperforming the S&P 500.
Best-in-Class Quant Score Makes AbbVie (ABBV) a Strong Buy
AbbVie Inc (NYSE:ABBV) ranks in the top 10% of its industry group, Biotechnology, and in the top decile of sector group, Health Care, with a…
What Are AbbVie Shareholders Getting for Their $21 Billion? (ABBV, PCYC, JNJ)
AbbVie (ABBV) beat Johnson & Johnson (JNJ) to the punch with the deal to acquire Pharmacyclics (PCYC), but was it worth the hefty price tag?
Why AbbVie Inc (ABBV) Stock Is Still a Long-Term Winner
The market has been hot and cold on biotechs, but AbbVie stock is a great long-term winner. Here’s what you need to know about ABBV.
ABBV Stock: Could AbbVie Inc’s Gamble on Stemcentrx Pay Off?
Stemcentrx’s acquisition does little to alleviate the risk of the potential decrease in sales once Humira loses patent protection.
AbbVie Stock News: Why ABBV Is the Top Trending Ticker Today
AbbVie stock is the top trending ticker on Yahoo Finance Thursday earnings news has ABBV investors pumped up this morning.
AbbVie Earnings: 5 Things for ABBV Stock Investors to Know About Q1
AbbVie (ABBV) earnings for the biopharmaceutical company’s first quarter of 2020 have ABBV stock on the move Friday after beating estimates.
AbbVie Inc (ABBV) Stock Isn’t Done Charting New Highs Yet
Pharma is a fast moving sector and the doors close quickly. With AbbVie’s (ABBV) door open, sell ABBV stock puts now!
8 – 10 of 240 results
